Anticipated peptide reclassification could expand the addressable market for PharmaTher's PharmaPatch™ product strategy and ...

Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.

What happens when a country at war stops seriously debating its own strategy and goals? In Israel today, that scenario is no ...

Nearly half of American adults over 30 have some form of gum disease, according to the Centers for Disease Control and ...

As active lifestyle nutrition expands beyond sports products into everyday wellness, Riya Jain explores how advances in ...

Founded in 1959, Groupe Rocher is a family-owned company with a deep heritage of pioneering development in natural, effective ...

| Future Market Insights NEWARK, Del., April 13, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global cold water swelling starch market is witnessing ...

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development ...

Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ...

Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by decades of advances in discovery, engineering, and manufacturing. Many ...

In parallel to developing new recycling solutions, the r-LightBioCom project is also rethinking how high-performance composites are manufactured, with a strong focus on energy efficiency, ...